June 07, 2006 07:15 ET

REMINDER: OR Live Presents Percutaneous Vertebroplasty, a Minimally Invasive Approach to Treat Vertebral Compression Fractures

Live Webcast June 7, 2006 at 4:00 PM CDT (21:00 UTC) From Saint Joseph's Hospital and Marshfield Clinic, Marshfield, WI

MARSHFIELD, WI -- (MARKET WIRE) -- June 7, 2006 --Over 700,000 vertebral compression fractures -- broken spinal bones -- occur annually in the United States. Many of these fractures result from untreated osteoporosis, and vertebral fractures can cause severe pain for nearly a third of people with the condition. On Wednesday, June 7, Marshfield Clinic physicians on staff at Saint Joseph's Hospital will discuss a leading surgical treatment for spinal compression fractures called percutaneous vertebroplasty. The program, featuring a pre-taped surgery of a vertebral compression fracture patient, will be webcast from 4 - 5 PM central daylight time. Expert commentary about the procedure will be provided by Fergus McKiernan, MD, metabolic bone disease specialist; Thomas Faciszewski, MD, orthopaedic surgeon; and Sanjay Rao, MD, neurological surgeon.

Vertebroplasty consists of injecting medical grade cement into fractured spinal bone to stabilize the fracture and reduce pain. The procedure has been available for the treatment of spinal compression fractures in the United States since 1995. Recently, Marshfield Clinic physicians reported the results of a landmark research study in The Journal of Bone & Joint Surgery, which demonstrated percutaneous vertebroplasty to be a safe and effective procedure to decrease pain and increase quality of life.

Marshfield Clinic and Saint Joseph's Hospital offer a comprehensive patient care approach to osteoporosis control and, if necessary, surgery to treat vertebral compression fractures. "In all too many cases the compression fracture is treated with vertebroplasty and the surgeon does not address the patient's underlying osteoporosis," Faciszewski said. "When the fracture is due to osteoporosis, it's more complicated. The fracture is a sign of a greater illness. Addressing the patient's metabolic bone disease at the same time as the fracture allows us to not only treat the fracture more effectively, but also help prevent subsequent fractures. The surgeon should not be the sole treatment provider -- we need to take a team approach to care for these patients."

Visit now to learn more and view a program preview. VNR:

For more information or for assistance accessing the webcast, please dial 1-888-mfld-4-or.

Contact Information

  • Contact:

    Alex Fraser
    Director of Marketing
    slp3D, Inc - OR-Live
    860-953-2900 x 214